CLOS
Compagnie Lombard Odier SCmA Portfolio holdings
AUM
$7.58B
This Quarter Return
+4.36%
1 Year Return
+23.11%
3 Year Return
+107.08%
5 Year Return
+161.87%
10 Year Return
+392.97%
AUM
$4.53B
AUM Growth
+$4.53B
(+17%)
Cap. Flow
+$524M
Cap. Flow
% of AUM
11.56%
Top 10 Holdings %
Top 10 Hldgs %
36.61%
Holding
723
New
123
Increased
148
Reduced
120
Closed
45
Top Buys
| 1 |
Adobe
ADBE
|
$36.9M |
| 2 |
Abbott
ABT
|
$24.2M |
| 3 |
Intellia Therapeutics
NTLA
|
$22.4M |
| 4 |
S&P Global
SPGI
|
$20.9M |
| 5 |
Tandem Diabetes Care
TNDM
|
$20.2M |
Top Sells
| 1 |
Walt Disney
DIS
|
$40.5M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$19.4M |
| 3 |
Apple
AAPL
|
$17.3M |
| 4 |
Futu Holdings
FUTU
|
$16.2M |
| 5 |
AbbVie
ABBV
|
$12.8M |
Sector Composition
| 1 | Healthcare | 22.18% |
| 2 | Communication Services | 16.63% |
| 3 | Technology | 16.07% |
| 4 | Financials | 13.49% |
| 5 | Consumer Discretionary | 12.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Novavax
NVAX
$1.2B
| $12.1M | 0.27% |
+66,902
| New | +$12.1M |
|
|
NVTA
77
DELISTED
Invitae Corporation
NVTA
| $11.7M | 0.26% |
+304,946
| New | +$11.7M |
|
78
Sangamo Therapeutics
SGMO
$161M
| $10.8M | 0.24% |
858,429
+848,429
| +8,484% | +$10.6M |
|
79
SPDR S&P 500 ETF Trust
SPY
$656B
| $10.7M | 0.24% |
26,948
-450
| -2% | -$178K |
|
80
NVIDIA
NVDA
$4.15T
| $10.5M | 0.23% |
19,615
-8,565
| -30% | -$4.57M |
|
81
American Well
AMWL
$112M
| $10.3M | 0.23% |
595,021
+593,441
| +37,560% | +$10.3M |
|
82
Exxon Mobil
XOM
$477B
| $10.2M | 0.23% |
183,409
-2,687
| -1% | -$150K |
|
83
Chubb
CB
$111B
| $10M | 0.22% |
63,553
-10,153
| -14% | -$1.6M |
|
|
OTRK
84
DELISTED
Ontrak
OTRK
| $9.66M | 0.21% |
+296,641
| New | +$9.66M |
|
85
TSMC
TSM
$1.2T
| $9.6M | 0.21% |
81,206
+15,767
| +24% | +$1.86M |
|
86
3M
MMM
$81B
| $9.48M | 0.21% |
49,226
+20,399
| +71% | +$3.93M |
|
87
Karyopharm Therapeutics
KPTI
$61.4M
| $8.73M | 0.19% |
+829,681
| New | +$8.73M |
|
88
Progressive
PGR
$145B
| $8.3M | 0.18% |
86,771
-3,385
| -4% | -$324K |
|
89
Quanterix
QTRX
$202M
| $8.12M | 0.18% |
+138,854
| New | +$8.12M |
|
90
Editas Medicine
EDIT
$225M
| $7.95M | 0.18% |
189,294
+189,194
| +189,194% | +$7.95M |
|
91
Electronic Arts
EA
$42B
| $7.85M | 0.17% |
58,000
+10,000
| +21% | +$1.35M |
|
92
Iovance Biotherapeutics
IOVA
$800M
| $7.66M | 0.17% |
+241,896
| New | +$7.66M |
|
93
Deere & Co
DE
$127B
| $7.54M | 0.17% |
20,148
+16,700
| +484% | +$6.25M |
|
94
International Flavors & Fragrances
IFF
$16.8B
| $7.47M | 0.16% |
53,500
-31,690
| -37% | -$4.42M |
|
|
MRTX
95
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.44M | 0.16% |
+43,428
| New | +$7.44M |
|
96
Teladoc Health
TDOC
$1.37B
| $7.16M | 0.16% |
39,378
+38,713
| +5,822% | +$7.04M |
|
97
iRhythm Technologies
IRTC
$5.67B
| $6.97M | 0.15% |
+50,181
| New | +$6.97M |
|
98
Dollar General
DG
$24.1B
| $6.74M | 0.15% |
33,243
+480
| +1% | +$97.3K |
|
99
Estee Lauder
EL
$33.1B
| $6.62M | 0.15% |
22,757
-2,027
| -8% | -$589K |
|
100
Sutro Biopharma
STRO
$85.6M
| $6.61M | 0.15% |
+290,418
| New | +$6.61M |
|